Latest / Bloomberg Intelligence
Novo Next-Generation Obesity Shot Falls Short of Lilly Rival
Watch Scarlet and Paul LIVE every day on YouTube: http://bit.ly/3vTiACF.
Market news and in-depth company research.
Bloomberg Intelligence hosted by Paul Sweeney and Scarlet Fu
-Sam Fazeli, Bloomberg Intelligence, Director of Research for Global Industries and Senior Pharmaceuticals Analyst, discusses Novo Nordisk’s next-generation obesity shot delivering less weight loss than Eli Lilly & Co.’s rival blockbuster in yet another blow to the Danish company’s attempts to regain lost ground in the weight-loss market.
-Michael Halen, Bloomberg Intelligence Senior Restaurant and…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.